info iconCurrently, the share price for Pfizer Ltd. is delayed.

close icon
Pfizer Ltd. Logo

Pfizer Ltd.

₹4,130.20
NSE
--   ( -- %) 1D



  • Prev. Close
    4,130.20
  • Upper Circuit
    4,956.20
  • Lower Circuit
    3,304.20

Returns

Pfizer Ltd.'s Info & Management

Established in 1950, Pfizer is one of the world’s leading pharmaceutical companies based in India. The company is involved in the manufacturing, marketing, trading, and export of pharmaceutical products. Additionally, it collaborates with several independent contract and third-party manufacturers located throughout India.

Business Segment

Its business operations are categorised into four segments: 

  • Vaccine Segment: focuses on Prevenar 13, a pneumococcal conjugate vaccine administered to infants as young as six weeks old as part of their primary vaccination, as well as to toddlers, adolescents, adults, and the elderly population
  • Inflammation and Immunology Segment: comprises two advanced therapies designed for patients dealing with chronic immune system-related diseases such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis, and ulcerative colitis
  • Internal Medicine Business: includes the primary care vertical and caters to millions of patients annually
  • Pfizer’s Hospital Business Unit (HBU): concentrates on institutions, including hospitals and nursing homes, by offering an advanced portfolio of anti-infective medications
  • Product Portfolio: covers vaccines, cardiac, pain, maternal nutrition, gastrointestinal, contraceptives, anti-inflammatory, nutrition, immunity, and respiratory

Geographical Presence

The company operates within and outside India.

  • Director(Regulatory Affairs)
    Dr. Manish Paliwal
  • Senior Director(Medical Affairs)
    Ms. Sudeshna Mitra
  • Director(People Excellence)
    Ms. Shilpi Singh
  • Category lead(Hospital)
    Ms. Shilpa Pradhan
  • Senior Director(Policy.,Public Affairs)
    Mr. Sharad Goswami
  • Director(Commercial,Market Access)
    Mr. Satyen Amin

FAQs on Pfizer Ltd.

What is the share price of Pfizer Ltd.?

Pfizer Ltd. share price is ₹4,143.35 as of April 22, 2024, 03:29 PM. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

What is the 52-week high and low of Pfizer Ltd.?

The 52-week high and low of Pfizer Ltd. is ₹5,000.00 and ₹3,733.00 respectively as of April 22, 2024, 03:29 PM. 52-week high and low represent the maximum and minimum value of the share price respectively, over the last 52 weeks (similar to 1 year).

What is the PB ratio of Pfizer Ltd.?

The trailing twelve month (TTM) PB ratio of Pfizer Ltd. is 5.90 as of April 22, 2024. The PB ratio measures the market capitalization of the company relative to it’s book value (carrying value on the balance sheet) as of last reported period.

What are the Upper Circuit and Lower Circuit of Pfizer Ltd.?

The Upper Circuit of Pfizer Ltd. is ₹4,956. The Lower Circuit of Pfizer Ltd. is ₹3,304.

What is the ROE of Pfizer Ltd.?

Pfizer Ltd. reported an ROE of 19.45% for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

What is the shareholding pattern of Pfizer Ltd.?

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Pfizer Ltd., Promoter held 63.9%, the FII held 3.3%, DII held 15.3% and the public held 17.4% of the total shares.

How to buy Pfizer Ltd. Share?

You can easily buy shares of Pfizer Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

What is the fair value of Pfizer Ltd.?

The fair value of Pfizer Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.
Trademarks owned by their respective owners and shown here only for ease of recall of the respective owner by public.Disclaimer